EUVIMEDDescubrir EUVIMED
Open access · CC BY 4.0

Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype

Camila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, Carolina DiBenedetto, Pedro J Salaberry, Roxana Pirker, Yizhuo Shen, Ons Zakraoui, Cecilia Schwarzer, Alessandro Scapozza, Joseph A Caruso, Paola Betancur and 7 more

Cellular and Molecular Life Sciences · 2025

DOI: 10.1007/s00018-025-05913-4 ↗

At a glance

Journal article in Cellular and Molecular Life Sciences, 2025. Written by Camila D Arcuschin and 18 co-authors. Institution: Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria…. Major MEDLINE topics: Breast Neoplasms, Transcription Factors, CD4-Positive T-Lymphocytes, DNA-Binding Proteins. Cited 3 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIH/NCI, NCI NIH HHS, Breast Research Development Program.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Despite efforts to understand breast cancer biology, metastatic disease remains a clinical challenge. Identifying suppressors of breast cancer progression and mechanisms of transition to more invasive phenotypes could provide game changing therapeutic opportunities. Transcriptional dysregulation is central to all malignancies, highlighted by the extensive reprogramming of regulatory elements that underlie oncogenic programs. Among these, super-enhancers (SEs) stand out due to their enrichment in genes controlling cancer hallmarks. To reveal novel breast cancer dependencies, we integrated the analysis of the SE landscape with master regulator activity inference for a series of breast cancer cell lines. As a result, we identified T - h elper-inducing Po xviruses and Z inc-finger ( PO Z)/ K rüppel-like factor (ThPOK, ZBTB7B ), a CD4 + cell lineage commitment factor, as a breast cancer master regulator that is recurrently associated with a SE. ThPOK expression is highest in luminal breast cancer but is significantly reduced in the basal subtype. Manipulation of ThPOK levels in cell lines shows that its repressive function restricts breast cancer cells to an epithelial phenotype by suppressing the expression of genes involved in the epithelial-mesenchymal transition (EMT), WNT/β-catenin target genes, and the pro-metastatic TGFβ pathway. Our study reveals ThPOK as a master transcription factor that restricts the acquisition of metastatic features in breast cancer cells.

Subjects

MeSH terms (MEDLINE)

Breast NeoplasmsTranscription FactorsCD4-Positive T-LymphocytesDNA-Binding ProteinsEnhancer Elements, GeneticHumansFemaleCell Line, TumorGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionPhenotypeCell LineageCell Movement

Author keywords

Extracellular matrixGene regulatory networksPlasticityTranscriptional repressors

Substances

Transcription FactorsDNA-Binding Proteins

Authors and institutions

  • Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.
  • Instituto de Fisiología, Biología Molecular y Neurociencias, Universidad de Buenos Aires, CONICET, Ciudad Universitaria, Buenos Aires, Argentina.
  • Department of Pediatrics, Benioff Children's Hospital at Oakland, University of California San Francisco, Oakland, CA, 94609, USA.
  • Lucira Health, Inc, Emeryville, CA, 94608, USA.
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, 94115, USA.
  • Harvard Medical School, Boston, MA, 02115, USA.

Funding

  • NIH/NCI
  • NCI NIH HHS
  • Breast Research Development Program
  • Pink Pumpkin Patch
  • Resource Allocation Program, UCSF
  • Swim Across America
  • Agencia Nacional de Promocion de Ciencia y Tecnologia
  • University of Buenos Aires

Cite

APA

Arcuschin, C. D., Kahrizi, K., Sayaman, R. W., DiBenedetto, C., Salaberry, P. J., Pirker, R., Shen, Y., Zakraoui, O., Schwarzer, C., Scapozza, A., Caruso, J. A., Betancur, P., Saba, J. D., Coppé, J. P., Barcellos-Hoff, M. H., Kappes, D., van 't Veer, L., Schor, I. E., & Muñoz, D. P. (2025). Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-025-05913-4

Vancouver

Arcuschin CD, Kahrizi K, Sayaman RW, DiBenedetto C, Salaberry PJ, Pirker R, et al. Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype. Cellular and Molecular Life Sciences. 2025. doi:10.1007/s00018-025-05913-4

BibTeX
@article{Arcuschin2025,
  author = {Arcuschin, Camila D and Kahrizi, Kamin and Sayaman, Rosalyn W and DiBenedetto, Carolina and Salaberry, Pedro J and Pirker, Roxana and Shen, Yizhuo and Zakraoui, Ons and Schwarzer, Cecilia and Scapozza, Alessandro and Caruso, Joseph A and Betancur, Paola and Saba, Julie D and Coppé, Jean-Philippe and Barcellos-Hoff, Mary-Helen and Kappes, Dietmar and van 't Veer, Laura and Schor, Ignacio E and Muñoz, Denise P},
  title = {Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype},
  journal = {Cellular and Molecular Life Sciences},
  year = {2025},
  doi = {10.1007/s00018-025-05913-4}
}
Start for free →